期刊文献+

克罗恩病与溃疡性结肠炎的时间结构式治疗方案 被引量:1

原文传递
导出
摘要 本文主要对所谓的时间结构式治疗方案(或称限时性方案),即不同疾病严重度的克罗恩病(CD)和溃疡性结肠炎(UC)患者的病情评估与推荐治疗方案进行了介绍,以达到促进临床上规范治疗IBD的目的。
作者 郑家驹
出处 《临床药物治疗杂志》 2011年第2期6-9,共4页 Clinical Medication Journal
  • 相关文献

参考文献13

  • 1Panaccione R, Rutgeerts P, Sandborn WJ, et al. Review article treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease [ J ] Aliment Pharmacol Thor.2008. 28 : 674- 688.
  • 2夏冰.重视对溃疡性结肠炎规范化的临床诊断与治疗[J].临床消化病杂志,2007,19(1):3-3. 被引量:24
  • 3Sandborn WJ. Currenl directions in IBD therapy: what goals are feasible with biological modifiers [J].Gastroenterol, 2009, 135 : 1442- 1445.
  • 4Panaecione R. Infliximab in inflammatory bowel disease future to your praetice today[J]. Landmark data in earl~ tients: time to change your praetice? BMJ Schring Plough te contents,2009 19:9- 12 IBD pa- Satel-lite contents,2009 19:9- 12.
  • 5Lang KA, Peppereorn MA. Medical therapy for Crohn's disease . In: Kirsner JB (ed.) lnflammalory Bowel Disease ,5th ed[M].W. B. Saunders Company, Philadelphia London New York St. Louis, Syd. 2000: 557- 577.
  • 6Hanauer SB, Kane S. The pharmacology of anti - inflammatory drugs in inflammatory bowel disease. In : Kirsner JB ( ed. ) lnflam matory Bowel Disease ,5th ed [M], W.B. Saunders Company. Philadelphia, London, New York, St. Louis, Syd. 2000: 510- 528.
  • 7Carter M J, Lobo AJ, Trvis SPL. Guidelines for the management of inflammatory bowel disease in adults [ J ]. Gut, 2004,53 :S5 : V1 - V16.
  • 8Trvis SPL, Stang EF, Lemann M, et al. European evidence based consensus pn the diagnosis and management of Crohn's disease: current management[J]. Gut, 2006, 55:Sl16-S135.
  • 9Liehtenstein GR, Abreu MJ, Cohen R, el al. American Gastroenter- ologieal Association Institute Medical Position Statement on Cortico- steroidss, lmmunomodulators, and [nfliximab in inflammatory Bow- el Disease[ J ]. Gastroenterol ,2006,130 : 935- 939.
  • 10Lichtenstein GR, Abreu M J, Cohen R, et al. American Gastroen- terological Association Institute Medical Position Statement on Corticosteroidss, lmmunomodulators, and Infliximab in inflammatory Bowel Disease[ J]. Gastroenterol,2006, 130 : 940- 987.

共引文献23

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部